Hinge Health, Inc. (HNGE)

NYSE: HNGE · Real-Time Price · USD

121.01

-0.71 (-0.58%)

Nov 12, 2026, 2:36 PM EST - Market open

Hinge Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	168.31	-528.26	-11.93	-108.14
Depreciation & Amortization	2.68	2.13	2.35	2.13
Other Amortization	74.24	49.67	33.51	23.84
Loss (Gain) From Sale of Investments	1.24	0.36	0.54	-10.76
Stock-Based Compensation	67.5	643.01	0.74	1.65
Provision & Write-off of Bad Debts	2.25	3.06	5.41	4.86
Other Operating Activities	0.47	3.49	4.88	13.11
Change in Accounts Receivable	-58.42	-26.63	-1.34	-23.13
Change in Inventory	-5.08	-4.76	0.61	10.57
Change in Accounts Payable	17.01	29.41	-10.98	11.56
Change in Unearned Revenue	157.9	83.22	77.16	35.97
Change in Other Net Operating Assets	-105.11	-83.25	-51.95	-25.56
Operating Cash Flow	322.99	171.44	49	-63.91
Operating Cash Flow Growth	121.40%	249.87%	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Capital Expenditures	-10.03	-0.71	-1.04	-1.98
Cash Acquisitions	-97.35	-4	-	-
Sale (Purchase) of Intangibles	-6.7	-5.36	-2.73	-2.64
Investment in Securities	88.91	-103.7	22.09	6.12
Investing Cash Flow	-25.17	-113.76	18.31	1.5

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Issuance of Common Stock	16.9	265.2	0.61	0.49
Repurchase of Common Stock	-361.74	-360.26	-	-
Other Financing Activities	-0.29	-55.42	-2.81	-3.49
Financing Cash Flow	-345.13	-150.47	-2.2	-3

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Cash Flow	-47.31	-92.79	65.11	-65.41

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	312.97	170.73	47.96	-65.89
Free Cash Flow Growth	115.20%	255.97%	-	-
Free Cash Flow Margin	39.08%	29.04%	12.29%	-22.51%
Free Cash Flow Per Share	3.74	3.13	3.54	-5.06
Levered Free Cash Flow	313.99	406.8	68.94	-
Unlevered Free Cash Flow	313.99	406.8	68.94	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash Income Tax Paid	1.56	1.56	-	-
Change in Working Capital	6.31	-2.01	13.5	9.41

SEC Filings: 10-K · 10-Q